Shijo, T.; Sakurada, Y.; Yoneyama, S.; Kikushima, W.; Sugiyama, A.; Matsubara, M.; Fukuda, Y.; Mabuchi, F.; Kashiwagi, K.
Association between Polygenic Risk Score and One-Year Outcomes Following As-Needed Aflibercept Therapy for Exudative Age-Related Macular Degeneration. Pharmaceuticals 2020, 13, 257.
https://doi.org/10.3390/ph13090257
AMA Style
Shijo T, Sakurada Y, Yoneyama S, Kikushima W, Sugiyama A, Matsubara M, Fukuda Y, Mabuchi F, Kashiwagi K.
Association between Polygenic Risk Score and One-Year Outcomes Following As-Needed Aflibercept Therapy for Exudative Age-Related Macular Degeneration. Pharmaceuticals. 2020; 13(9):257.
https://doi.org/10.3390/ph13090257
Chicago/Turabian Style
Shijo, Taiyo, Yoichi Sakurada, Seigo Yoneyama, Wataru Kikushima, Atsushi Sugiyama, Mio Matsubara, Yoshiko Fukuda, Fumihiko Mabuchi, and Kenji Kashiwagi.
2020. "Association between Polygenic Risk Score and One-Year Outcomes Following As-Needed Aflibercept Therapy for Exudative Age-Related Macular Degeneration" Pharmaceuticals 13, no. 9: 257.
https://doi.org/10.3390/ph13090257
APA Style
Shijo, T., Sakurada, Y., Yoneyama, S., Kikushima, W., Sugiyama, A., Matsubara, M., Fukuda, Y., Mabuchi, F., & Kashiwagi, K.
(2020). Association between Polygenic Risk Score and One-Year Outcomes Following As-Needed Aflibercept Therapy for Exudative Age-Related Macular Degeneration. Pharmaceuticals, 13(9), 257.
https://doi.org/10.3390/ph13090257
